データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Neuren Pharmaceuticals Says Partner Acadia Completes Sale of Rare Pediatric Disease Priority Review Voucher
Neuren Pharmaceuticals Limited's (ASX:NEU) Intrinsic Value Is Potentially 60% Above Its Share Price
My 2 Best ASX Growth Shares to Buy in November
These ASX 200 Growth Shares Could Rise 50% to 60%
New Forecasts: Here's What Analysts Think The Future Holds For Neuren Pharmaceuticals Limited (ASX:NEU)
Neuren Pharmaceuticals to Launch AU$50 Million Share Buyback; Shares Up 6%